ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2225

Twitter and Rheumatology: Significant and Incremental Growth in Usage

Ahmed Omar1, Ismail Sari1, Jonathan Chan2, Nigil Haroon1 and Robert D Inman3, 1Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 2Rheumatology, Spondylitis program, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 3Immunlogy and Institute of Medical Science, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: educational innovation, internet, social media and technology, Twitter

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Education Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

 

Background/Purpose:

The continued growth of social media has
allowed people to rapidly communicate, share, and develop ideas and
information.  Twitter is an online social networking service which allows users
to submit and to read short 140-character messages called "tweets". Since
its creation in 2006, its user base has continued to grow with a currently estimated
number of active users of half a billion. In addition, sixty million tweets are
estimated to be generated each day.

Used
correctly, Twitter can be a valuable portal to educate patients, share research
ideas and findings and increase awareness of important health-related issues.

With regards to the subject of
Rheumatology, there is lack of knowledge in terms of its online twitter
presence and its development over the years.

The aim of this study is to highlight the
use of Twitter in relation to Rheumatology. To the best of our knowledge, no
previous research has examined this subject.

 

Methods:

The Symplur® healthcare analytics website
was used to retrospectively examine traffic related to chosen Rheumatology-associated
hashtags.  Symplur® was used to generate statistics for the number of
impressions, unique tweets (excluding retweets) and number of participants. Some
of the hashtags that were chosen include: #Rheum, #Lupus, #Fibro, #Arthritis,
#Osteoporosis, #Spondylitis (AS), #RheumatoidArthritis, and #Vasculitis.
#Diabetes, #IBD  (Inflammatory Bowel Disease), and #Psoriasis were also chosen
as comparators.  Statistics were obtained from a 5 year period (2010 to 2014).

 

Results:

The total number of  Rheumatology-related
tweets related to the major hashtags grew from only 319 tweets in 2010 to
497,595
tweets in 2014 (Fig. 1a). The #Lupus hashtag showed the most activity, followed
by #Fibro (fibromyalgia), #Arthritis and #Rheum.

Between the years 2013 and 2014, there was an average growth in
number of total tweets by 37%. When comparing #Diabetes with Rheumatology-related
hashtags in 2014, there were a total of 1,037,211 tweets related to #Diabetes vs
538,186 tweets related to Rheum hashtags (Fig.  1b).

In terms of number of contributors, in 2014, there were a total of
135,237
participants using Rheumatology-related hashtags.  When
looking at influence, the top 10 contributors tweeting in the #lupus, #RheumatoidArthritis
and #Spondylitis hashtags contributed 12.6 %, 11% and 61.4% of total number of
tweets respectively.

 

Conclusion : Twitter
usage in relation to Rheumatology has shown a dramatic growth over the last 5
years and continues to show sustained growth.  These novel findings suggest
that this social media portal has the potential to be a valuable tool in
informing and shaping Rheumatology-related healthcare.

 


Disclosure: A. Omar, None; I. Sari, None; J. Chan, None; N. Haroon, None; R. D. Inman, None.

To cite this abstract in AMA style:

Omar A, Sari I, Chan J, Haroon N, Inman RD. Twitter and Rheumatology: Significant and Incremental Growth in Usage [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/twitter-and-rheumatology-significant-and-incremental-growth-in-usage/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/twitter-and-rheumatology-significant-and-incremental-growth-in-usage/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology